Table 2.
Genotype | coelomocytes cup-4::GFP1 |
pharynx cells pha-4::GFP1,2 |
---|---|---|
Wild type (N2) | 3.7 ± 0.2 (105) | 50.0 ± 0.9 (21) |
pop-1(RNAi) | 0.0 ± 0.0 (50) | 21.3 ± 0.8 (18) |
glp-1(RNAi) | nd | 23.1 ± 0.6 (15) |
end-1(ok558) end-3(ok1448) | 4.5 ± 0.1 (65) | 49.1 ± 1.0 (10) |
end-1(ok558) end-3(zu247) | 4.6 ± 0.1 (77) | 51.1 ± 1.3 (15) |
end-3(ok1448); pop-1(RNAi) | 6.1 ± 0.2 (77) | 28.5 ± 7.0 (22) |
end-1(ok558) end-3(zu247); pop-1(RNAi) | 9.3 ± 0.2 (80) | 43.5 ± 1.3 (23) |
end-1(ok558) end-3(ok1448); pop-1(RNAi) | 10.7 ± 0.3 (77) | 44.8 ± 2.2 (17) |
end-3(ok1448); glp-1(or178) | nd | 21.2 ± 0.8 (18) |
end-3(ok1448); glp-1(or178); pop-1(RNAi) | nd | 9.5 ± 0.8 (75) |
end-1(ok558) end-3(ok1448); glp-1(or178) | nd | 25.2 ± 1.0 (17) |
end-1(ok558) end-3(ok1448); glp-1(or178); | nd | 16.8 ± 1.1 (93) |
pop-1(RNAi) | ||
end-1(ok558) end-3(ok1448); glp-1(or178); | nd | 1.4 ± 0.3 (40) |
pop-1(RNAi); Ex[end-1,3(+)] | ||
med-1(ok804); med-2(cx9744) | 0.1 ± 0.0 (34) | 31.3 ± 0.6 (26) |
ceh-51(tm2123); tbx-35(tm1789) | 0.2 ± 0.0 (124) | 30.2 ± 0.5 (44) |
med-1(ok804); med-2(cx9744); end-1(ok558) | 0.0 ± 0.0 (52) | 29.9 ± 1.1 (12) |
end-3(ok1448)3 | ||
med-1(ok804); med-2(cx9744); end-1(ok558) | 1.0 ± 0.2 (57) | 22.4 ± 0.9 (24) |
end-3(ok1448); pop-1(RNAi)3 | ||
end-1(ok558) end-3(ok1448) ceh-51(tm2123); | 0.1 ± 0.0 (122) | 30.3 ± 1.0 (21) |
tbx-35(tm1789) | ||
end-1(ok558) end-3(ok1448) ceh-51(tm2123); | 0.1 ± 0.1 (35) | 22.1 ± 1.4 (19) |
tbx-35(tm1789); pop-1(RNAi) |
Some data are from Broitman-Maduro et al. 2009.
Expression of pha-4 in gut and/or rectum cells (if present) was not included.
Embryos were also homozygous for dpy-11(e224).